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Abstract: 
Background: Aerosol production during normal breathing is often attributed to 
turbulence in the respiratory tract. That mechanism is not consistent with a high 
degree of asymmetry between aerosol production during inhalation and exhalation. 
The objective was to investigate production symmetry during breathing. 
 
Methods: The aerosol size distribution in exhaled breath was examined for different 
breathing patterns including normal breathing, varied breath holding periods and 
contrasting inhalation and exhalation rates. The aerosol droplet size distribution 
measured in the exhaled breath was examined in real time using an aerodynamic 
particle sizer. 
 
Results and Conclusions: The dependence of the particle concentration decay rate on 
diameter during breath holding was consistent with gravitational settling in the 
alveolar spaces. Also, deep exhalation resulted in a 4 to 6 fold increase in 
concentration and rapid inhalation produced a further 2 to 3 fold increase in 
concentration. In contrast rapid exhalation had little effect on the measured 
concentration. A positive correlation of the breath aerosol concentration with subject 
age was observed.  
 
The results were consistent with the breath aerosol being produced through fluid film 
rupture in the respiratory bronchioles in the early stages of inhalation and the resulting 
aerosol being drawn into the alveoli and held before exhalation. The observed 
asymmetry of production in the breathing cycle with very little aerosol being 
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produced during exhalation, is inconsistent with the widely assumed turbulence 
induced aerosolization mechanism. 
 




According to the findings of the American Thoracic Society/European Respiratory 
Society Task Force (ATS/ERS TASK FORCE) on Exhaled Breath Condensate 
(EBC)1, the important areas for future research include: ascertaining the mechanisms 
and site of exhaled breath condensate particle formation; determination of dilution 
markers; improving reproducibility; employment of EBC in longitudinal studies; and 
determining the utility of exhaled breath condensate measures for the management of 
individual patients. The first of these requirements concerns the identification of the 
source region and mechanism responsible for producing the aerosol present in exhaled 
breath. As stated by the authors of that report, the mechanisms which cause 
airway/alveolar fluid substances or those from the mucus layer to be added to exhaled 
breath are not clear and further study is required. These droplets of respiratory fluid 
may be released anywhere between the alveoli and mouth2. 
 
According to Wood eta al.3; while there is an intuitive explanation for the presence of 
volatile substances in exhaled breath, the mechanisms by which non-volatile 
substances enter expired breath are poorly understood and need further investigation. 
 
Existing models of breath aerosol formation assume that turbulence, occurring in the 
respiratory tract results in the aerosolization of respiratory fluid 4-6. That model does 
not adequately explain the influence that respiratory activities exert on aerosol 
concentration: Experimental data do not show a clear increase in aerosol 
concentration with exhalation flow rate during breathing, as should occur if turbulent 
airflow is the dominant breath aerosol formation mechanism. In fact normal breathing 
can produce higher aerosol number concentrations than coughing 4, 6, 7 which involves 
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far higher flow rates. Gebhart et al.8 found that these particles are expired from 
volumetric lung depths of more than 200 cm-3 implying that they occur beyond the 
conducting airways. They also observed that the concentration decreased following 
breath holding, and suggested the opening of closed peripheral airways as a possible 
mechanism of generation of these particles.  
 
Turbulence is associated with high Reynolds number (Re). During quiet breathing (<1 
L.s-1), airflow in the trachea is partly turbulent, with a Reynolds number of about 
1500, however Re deceases deeper in the respiratory tract and flow in the bronchi is 
turbulent only at very high flow rates (5 L.s-1) and it is laminar in the bronchioles at 
all naturally achieved flow rates9. Authors have previously pointed this out showing 
that aerosol production induced by turbulent flow is unlikely in the lower respiratory 
tract during normal breathing because airflow is laminar in the medium through to 
smaller bronchial airways down to and including the alveoli10. Therefore for normal 
breathing, the turbulence induced aerosolization mechanism must assume that aerosol 
formation occurs in the larynx or perhaps at bifurcations where local eddies can occur. 
Studies examining the composition of the aerosol question this assumption however. 
 
Expired breath condensate contains non-volatile solutes produced primarily in the 
region of the deeper bronchiolar/alveolar region. Effros et al.11 found that after 
adjusting expired breath condensate concentrations for dilution, and obtaining the 
original concentration of non-volatile solutes in the lining fluid (from which the 
aerosol was presumed to be derived), higher concentrations of Ca2+ cation were found 
than occurs naturally in plasma. This was attributed to the surfactant known to be 
generated in the distal parts of the lung, not the higher respiratory tract. Therefore this 
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material must be assumed to have been carried to the higher parts of the respiratory 
tract in order to retain the previous assumption.  
Model description: 
An alternate, very simple model of breath aerosol formation which addresses the 
above inconsistencies is described. The mechanism is based on a process of 
respiratory fluid film or bubble bursting during the clearance of fluid closures which 
form in the lower bronchioles following exhalation. The model is referred to as the 
bronchiole fluid film burst (BFFB) model. 
 
The BFFB model relies on the following details concerning the physiology and 
physics of breathing which are well documented in the literature. A schematic 
representation of a section of bronchiole is shown in figure 1 where the processes 
discussed below are represented in a highly exaggerated way. During normal 
breathing in a healthy subject during exhalation, fluid which lines the surface of the 
elastic respiratory bronchioles, is expelled from spaces in the longitudinal folds in the 
bronchiolar surface as those spaces contract as per stages A-C in the figure. This 
process continues, eventually resulting in a more or less flat, continuous fluid layer 
over the interior surface of the bronchiole (B). It should be noted that in reality the 
respiratory fluid may contain air bubbles so that it resembles a foam rather than a pure 
liquid phase. 
 
The surface tension of this now much reduced area of film, acts to draw the highly 
compliant airway closed even further. This is in accordance with the so-called Law of 
Laplace which shows that a small tube will experience a greater inward force (due to 
the surface tension of the lining fluid) than a large one even if their surface tensions 
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are equal. It must be noted at this point that a natural surfactant is present in this fluid 
and this acts to prevent the total collapse of most of the small airways because the 
surfactant, which reduces surface tension, is confined to the air water interface and 
therefore becomes more concentrated as the area of the interface decreases. 
Neverthesless, in some respiratory bronchioles, the remaining thin column of air 
collapses to such an extent that at some narrower points along the bronchiole the 
liquid film can completely block the airway (C). Due to the forces associated with 
fluid surface tension and reduced dimension, a higher pressure difference is required 
to reopen this airway, than was required to close it, even though this difference is 
substantially moderated by the presence of surfactant in the fluid12. The reopening of 
such closed airways occurs during the early stages of subsequent inhalation phase of 
the breathing cycle.  
 
The following is a logical inference based on the above known physiology: During 
the reopening of a respiratory bronchiole, the fluid blockage will contract axially 
(transition from C to D in figure 1) as it is drawn radially outward by the expanding 
bronchiole, until the blockage is reduced to a thin membrane or bubble (state D in 
figure 1). The bubble subsequently bursts, reopening the airway (E). The film 
breakage will be accompanied by the fragmentation of fluid film as in the bursting of 
fluid bubbles generally. Film droplet aerosol production from bursting bubbles is well 
documented. For comparison seawater produces film droplets drying to equilibrium 
diameters in the range 0.25-2 µm13. These form at the ocean surface when bubbles of 
surfactant matter form and burst after entrained air bubbles rise to the ocean surface.  
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This above model is consistent with the observation that aerosol production increases 
as breathing becomes deeper and faster6, since deeper exhalation is accompanied by 
greater reduction in bronchiolar diameter, and therefore a greater number of fluid 
blockages will be reopened. 
 
Experimental evidence supporting the film droplet production mechanism as a source 
of aerosol droplets in exhaled air during normal breathing is presented in the 
following section. 
 
Materials and Methods 
Subjects 
The experimental study was fully scrutinised and cleared by the Queensland 
University of Technology Human Research Ethics Committee. Subjects aged between 
19 and 60 years of age were recruited via a broadcast email invitation offering a small 
financial reward. Subjects were instructed to self exclude if they were smokers, 
experiencing illness, asthma sufferers, had recently experienced expiratory problems 
or were likely to experience discomfort in confined spaces. In total 17 subjects 
participated in the study. 
Study Design  
Objectives 
The primary study objectives were: 
 To determine whether breath aerosol is produced equally during the inhalation 
and exhalation phases of breathing.  
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 To determine the influence of exhalation depth on the droplet number 
concentration of breath aerosol in the subsequent breath. 
 To identify approaches for controlling and enhancing the production of breath 
aerosol through modified breathing patterns as a potential means to facilitate 
studies involving the collection and analysis of expired breath condensate and 
expired aerosol. 
 
An additional objective was to detect any correlation of breath aerosol concentration 
with age. 
 
Overview of experiments 
Subjects were asked to perform several respiratory activities, during which the aerosol 
size distribution and concentration were measured. Water vapour concentration was 
used as a tracer of dilution during these measurements so that the concentration within 
the respiratory tract could be determined. 
Methods 
This research utilised the Expiratory Droplet Investigation System (EDIS) which is 
described in detail elsewhere14. The EDIS, shown schematically in figure 2, is a small 
wind tunnel 0.5 m in diameter, into which a subject can comfortably insert their head. 
HEPA filtered, recirculating air is propelled by a filter/fan module past the subject at a 
very low, controlled velocity. The particle free air carries any aerosol emitted by the 
subject to instrument sampling ports positioned inside the duct at a set distance 
downwind. The EDIS operates at slightly higher than ambient pressure to ensure that 
no ambient aerosol enters to contaminate the sample.  
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Aqueous aerosols dry rapidly to an equilibrium diameter determined by the relative 
humidity at the point and time of measurement and the hygroscopicity of the non-
volatile components of the aerosol material. In the case of respiratory fluid these may 
include hygroscopic salts such as NaCl and organic materials including surfactant 
which may also affect the rate of evaporation. The aforementioned study by 
Morawska, et al.14 showed that respiratory aerosols examined using the APS in the 
EDIS have achieved their equilibrium size when measured.  
 
Aerosol size distributions in the diameter range 0.5-20µm were measured using an 
Aerodynamic Particle Sizer (APS) (TSI model 3312A). The APS measures the 
aerodynamic particle size distribution, which assumes unit density particles, spherical 
in shape. The aerodynamic diameter is likely to be a good approximation to the 
physical size both for droplets which are primarily aqueous and for dried residue 
particles, comprised mainly of organic matter if these have formed through the drying 
of initially spherical droplets and retain this shape on drying. Additional 
instrumentation included a relative humidity probe (Hygropalm Hycroclip) 
incorporated into the UV-APS probe tube extension to determine the water vapor 
concentration in the sample stream and a hot wire anemometer probe (TSI 
Velocicheck™ 8340) which determined the air velocity in the duct during aerosol 
measurements. 
 
Breath emissions have been linked to depth in the respiratory tract by examining the 
time of emission within the breathing cycle. This approach requires a sufficient 
concentration of the target emission to overcome background noise in concentration 
reading. This was not possible with the APS aerosol concentration measurements 
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because of the very low concentrations involved, the small sample flow rate. The 
current approach instead uses only the average exhalation concentration per breath. 
 
Aerosol dilution (D) was estimated via Equation 1 and  
Equation 2 using water vapour concentration as a tracer and the resulting dilution 
factors were used to correct for dilution and obtain droplet number concentration in 
the respiratory tract. 
 
Equation 1: Calculation of the sample dilution factor from water vapour 
concentration 
EDIS in theion concentratvapor air water  background 
sample in theion concentrator  water vap

















Equation 2: Calculation of absolute humidity or water vapour concentration from 
relative humidity and temperature 
(K) re temperatu
constant gas  
 waterofweight molecular   
Tat  water of pressure vapour saturation   


























The accuracy of the dilution correction depends on the accuracy of the assumed water 
vapour concentration inside the mouth during exhalation which we treat as a fixed 
value (3.3x10-2 kg.m-3), derived from published data14-18. Based on the wide 
 11
variations in the published data and in the accuracy of the water vapour concentration 
measurements, we ascribe an uncertainty to the dilution factors of 30 %. 
 
Size distribution measurements for each subject, were conducted over three sessions 
at approximately 2 hour intervals. The sessions consisted of a sequence of activities 
defined in table 1, with each activity lasting 2 minutes. The sessions were repeated 
three times, with 20 minute rest periods between the sessions. The resulting size 
distributions were corrected for dilution to obtain the concentration in the respiratory 
tract. The average size distribution was then calculated for each activity across all 
subjects.  
 
For normal breathing, the average breathing cycle duration based on breath count and 
activity duration, ranged from 1.7 to 10.9 s with an average of 4.1 s. This is not the 
same as the duration of inhalation and exhalation since that includes a brief (about 0.5 
s) pause after exhalation. Allowing for this pause, the duration of the average normal 
inhalation/exhalation is approximately 3.5 s. 
 
Inhalation via the mouth was employed during the modified breathing patterns b-3-0-
f1–m-m, b-1-t-f3-m-m and b-3-0-f3–m-m (table 1) because it was necessary for rapid 
inhalation which would otherwise be restricted by the nasal passages in nasal 
inhalation. 
Results 
Depth and rate of exhalation 
Figure 3 shows the average concentration as well as the average of the concentration 
enhancements over normal breathing for breath aerosol concentration during four 
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breathing patterns. All modified breathing patterns gave rise to a significant 
enhancement over normal breathing. The enhancement was attributed to the deep 
exhalation in those activities which did not occur during normal breathing. There was 
not a statistically significant difference between the enhancements obtained for rapid 
exhalation and slow exhalation. In contrast to this, rapid inhalation produced a 
significant and substantial increase, reaching 30 times the normal breathing 
concentration for one subject. 
 
Deep exhalation prior to drawing a breath resulted in an increase in the average 
concentration across all subjects by a factor of 5.5 ± 3.5. 
 
Fast inhalation versus fast exhalation 
The role of flow rate was investigated by comparing aerosol production during fast 
inhalation with that during fast exhalation. Figure 4 shows the average size 
distribution obtained from the activity b-1-0-f3-m-m (rapid inhalation, no breath 
holding, full slow exhalation, table 1) and b-3-0-f1-m-m (slow inhalation, no breath 
holding, full rapid exhalation) for two subjects. The average size distribution for 
normal breathing (b-n-m) is shown for comparison. In both subjects deep exhalation 
produced clear increases in the concentration over normal breathing; however the 
increase was much greater with rapid inhalation than with rapid exhalation.  
Gravitational deposition in the alveoli of aerosol generated through inhalation. 
Figure 5 shows the average measured size distribution for young (age ≤ 35) subjects 
for breathing with full deep exhalation and subsequent rapid inhalation over a 1 
second period, followed by breath holding for 0 s, 2 s, 5 s and 10 s, then exhalation 
over a 3 s period.  
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The size distribution shows distinctive erosion of particle concentration, which 
progressively moves from large to smaller sizes as the duration of breath holding 
increases. This pattern is strongly suggestive of gravitational settling where larger 
particles which fall with greater terminal velocity are lost earlier. This is potentially 
strong evidence that the aerosol is formed primarily during the inhalation rather than 
the exhalation phase of breathing.  
 
Most of the available storage volume of the lung is in the alveolar spaces, and the 
dimension and geometry of these spaces is known to be a multifaceted prism which 
approximates a spear of diameter 0.2 mm. Gravitational settling in such a space can 
be modelled using equation 1 which describes the decay in particle concentration with 
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Also shown in Figure 5 are the predicted size distributions based on the 0 s breath 
holding case, assuming gravitational settling in a well mixed 0.2 mm diameter 
spherical volume similar to that of the alveoli. Here we have adopted the hygroscopic 
growth assumption employed by Nicas et al.20, who showed that droplets in the 
respiratory tract shrink by a factor of roughly 0.5 when exposed to ambient relative 
humidity. Therefore the diameter of the droplets in the saturated environment of the 
alveoli is assumed to be two times larger than the size measured. Figure 6 shows the 
result for a single subject using the same model assumptions. 
 
The size distribution is affected by the detection efficiency of the 3320 APS which is 
known to decline from 100% at 0.9 µm to about 30% at 0.5 µm µm21. This accounts 
for the increasing discrepancy with decreasing diameter, between the modelled and 
measured values below 1 µm. 
 
Correlation of Breath aerosol concentration with age of subject. 
Figure 7 shows the relationship between breath aerosol concentration and subject age 
for normal breathing.  A positive and statistically significant correlation (p=0.02) was 
observed between concentration and subject age, implying that breath aerosol 
production increases with age. It should be noted that most of the subject ages are 
located in a cluster at the lower end of the age range and this may reduce the validity 
of the statistical test. However it should also be noted that the eldest subject tested 
(identified as an outlier or “super emitter”) produced concentrations more than an 
order of magnitude greater than the mean, and this subject was excluded from the 
above regression analysis on the assumption that their lung function was different in 
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some way from the remaining group. No conventional lung function testing was 
performed on the subjects. 
Discussion 
When interpreting the concentration data for contrasting depths and rates of 
exhalation it should be noted that the cartilaginous airways become somewhat 
compressed during forced expiration22. This will enhance the increases in velocity and 
turbulence expected during fast exhalation. It is therefore likely that a greater 
proportion of larger droplets are lost through airway inertial impaction during forced 
exhalation than during fast and normal exhalation. However in the airways, particle 
loss through inertial impaction occurs primarily for particles or droplets larger than 5 
µm23, and this occurs on surfaces in the upper respiratory tract where the velocity is 
higher. The vast majority of the droplets observed in this study were smaller than 2 
µm so impaction losses in terms of the faction of total particle number lost are likely 
to be small. This is confirmed in figure 3 which shows that impaction losses did not 
significantly alter the number concentration when only the exhalation rate was 
changed, although a small statistically non-significant decrease in the concentration 
enhancement with respect to normal breathing can be seen for fast exhalation. 
 
It is also important to note that deep exhalation is usually followed by deeper than 
normal inhalation, so although the inhalation rate was controlled to match as closely 
as possible, the duration of normal breathing inhalation, the volume of air inspired 
during a 3 second inhalation was probably greater following deep exhalations than in 
normal breathing. Therefore it is possible that the increased concentrations observed 
following deep exhalation were partly due to a higher flow rate during inhalation.  
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Nevertheless, the observation that rapid inhalation produced much greater increases in 
concentration than occurred with rapid exhalation is not consistent with a model 
employing turbulence induced aerosolization in the higher respiratory tract. 
Furthermore, in the higher respiratory tract the airways are supported by a more rigid 
cartilaginous reinforcement, and so are less pliable and do not close readily12. In fact 
as previously discussed, these airways may compress during forced expulsion, so it is 
probable that air velocity in this region is actually higher for fast exhalation than is the 
case for fast inhalation. 
 
Given the longer residence time in the respiratory tract for aerosols generated during 
inhalation the turbulence mechanism should have produced the opposite outcome to 
that observed as greater concentrations would be expected for fast exhalation than for 
fast inhalation. 
 
Interpretation of the results in terms of the aerosol formation mechanism. 
The increased concentration observed for deep exhalation supports the proposed 
BFFB mechanism where the aerosol is formed from fluid blockages of the 
bronchioles since these should become more common as the lung becomes more 
deeply deflated. 
 
The observation that there is no consistent increase in aerosol production when the 
exhalation rate is increased by a factor of three, supports the concept that the aerosol 
is not produced by turbulence in the airways, as this would produce aerosol equally 
during inhalation and exhalation. 
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The observation that aerosol production increases when the inhalation rate is 
increased by a factor of three supports the concept that the aerosol is produced during 
the inhalation phase of breathing. Rapid inhalation will produce a greater pressure 
drop across the bronchiole fluid closures so that a greater proportion of these closures 
are expected to reopen during fast inhalation. Therefore, the observation of increased 
production is also consistent with the fluid closure and film burst aspect of the model.  
 
The observation that gravitational settling losses increase with increased breath 
holding duration and that this behaviour is consistent with the droplet size and the 
dimension of the alveoli, further supports a model where aerosol is produced mainly 
during the inhalation phase of breathing. 
 
It is worth noting that Edwards et al.7 showed that delivering an aerosolised surfactant 
solution to the lungs increases exhaled aerosol concentration during normal breathing 
30 fold. Surfactants have a well known ability to increase aqueous film elasticity, 
thereby allowing bubbles to form readily and to achieve much larger diameters before 
bursting. This may also be consistent with the BFFB model, as bubbles will burst later 
in the inhalation phase when they, along with the bronchiolar diameter, are much 
larger. 
 
When interpreted in the context of the BFFB model the existence of a positive 
correlation between breath aerosol concentration and age appears to suggest age 
related changes in the bronchiole structures, changes in the surfactant properties of the 
lining fluid or changes in breathing pattern which accentuate the BFFB process. 
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In summary, breath aerosol production occurs during the initial stages of inhalation, 
and the resulting aerosol concentration is proportional to the fraction of fully 
contracted bronchioles with blockages at the onset of inhalation and inversely related 
to the duration of breath holding. 
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Table 1: Breathing activity labels and their definitions 
Activity label Activity Description 
b-n-m Breathing normally, inhaling via the nose and exhaling via the 
mouth, repeated for 2 minutes. 
b-3-0-f1-m-m Inhaling a normal* breath volume via the mouth over a 3 s period, 
followed immediately by a 1 second, full, deep exhalation via the 
mouth. Repeated for 2 minutes. 
b-1-t-f3-m-m Rapid inhalation of a normal* breath volume via the mouth over a 
1 s period, followed by breath holding for a period of t s, then full, 
deep exhalation via the mouth over a 3 s period. Repeated for 2 
minutes. 
b-3-0-f3-m-m Inhaling a normal* breath volume via the mouth over a 3 s period, 
followed immediately by a 3 second full, deep exhalation via the 
mouth over a 3 s period. Repeated for 2 minutes. 
 normal breath volume means a normal breath volume as judged by the subject. 
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Figure 1: Conceptual illustration of the BFFB mechanism occurring in a bronchiole 
Figure 2: Conceptual schematic of the EDIS wind tunnel. 
Figure 3: Mean concentrations and corresponding concentration enhancements over normal 
breathing, for three repeats with 13 subjects under the age of 36y, for four breathing patterns. 
The error bars show the standard error of the mean concentration. 
 
Figure 4: Average dilution corrected expired aerosol size distribution for 2 subjects. 
 
Figure 5: Average measured size distribution for young subjects for full exhalation with 
subsequent rapid inhalation over a 1 second period followed by breath holding for 0 s, 2 s, 5 s 
and 10 s, then exhalation over a 3 s period. Also shown are the predicted size distributions based 
on the 0 s breath holding case, assuming gravitational settling in a well mixed 0.2 mm diameter 
spherical volume (similar to that of the alveoli) assuming that the measured droplet diameter is 
half that of the droplets when in the saturated environment of the alveoli. 
 
Figure 6: Measured size distribution for a 41 year old subject for rapid inhalation over a 1 
second period followed by breath holding for 0 s, 3 s and 10 s, then full (deep) exhalation over a 3 
s period. Also shown are the predicted size distributions based on the 0 s breath holding case, 
assuming gravitational settling in a well mixed 0.2 mm diameter spherical volume (similar to that 
of the alveoli) assuming that the measured droplet diameter is half that of the droplets when in 
the saturated environment of the alveoli. 
 
Figure 7: Average breath aerosol droplet number concentration versus subject age. 
 
 
 
 
 
 
